Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis
Background: Proton pump inhibitors (PPI) are generally considered to be one of the well-established prescription drug classes and are commonly used to treat most acid-related diseases. However, a growing body of literature showing an association between gastric and colorectal cancer risk and PPI use...
Saved in:
Main Authors: | Huizhu Guo (Author), Ruiqiu Zhang (Author), Pei Zhang (Author), Zhaoyang Chen (Author), Yuqing Hua (Author), Xin Huang (Author), Xiao Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021) -
Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis
by: Wan-Ying Lin, et al.
Published: (2022) -
Proton-pump Inhibitors and the Risk of Dementia: A Systematic Review and Meta-analysis
by: Kyu-Tae Yoon, et al.
Published: (2021) -
Long-term proton pump inhibitors use and its association with premalignant gastric lesions: a systematic review and meta-analysis
by: Zeyi Zheng, et al.
Published: (2023) -
Clinicians should be aware of proton pump inhibitor-related changes in the gastric mucosa
by: Gwang Ha Kim
Published: (2024)